913839-73-3

Usage

Uses

Used in Pharmaceutical Industry:
(6-Trifluoromethyl-pyridin-3-yl)-acetic acid is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure, including the electron-withdrawing trifluoromethyl group and the acetic acid functionality, may contribute to the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, (6-Trifluoromethyl-pyridin-3-yl)-acetic acid may serve as a building block for the creation of novel agrochemicals. Its chemical properties could be harnessed to develop pesticides or herbicides with improved efficacy and selectivity.
Used in Materials Science:
(6-Trifluoromethyl-pyridin-3-yl)-acetic acid has potential applications in materials science, where its unique chemical structure could be utilized to design and synthesize new materials with specific properties. These materials could find use in various industries, such as electronics, coatings, or adhesives, where novel properties are sought after.
Overall, the diverse applications of (6-Trifluoromethyl-pyridin-3-yl)-acetic acid across different industries highlight its versatility and the potential for further research and development in these areas.

Upstream product

• 1257088-58-6 ethyl 2-cyano-2-[6-(trifluoromethyl)-3-pyridyl]acetate 
• 936841-73-5 5-fluoro-2-(trifluoromethyl)pyridine 
• 765298-04-2 2-(6-(trifluoromethyl)pyridin-3-yl)acetonitrile 
• 386704-04-7 6-(trifluoromethyl)pyridin-3-ylmethanol 

Downstream Products

• 917486-25-0 N'-(5-bromo-4-(4-chlorophenyl)pyridin-2-yl)-2-(6-(trifluoromethyl)pyridin-3-yl)acetohydrazide 
• 1201194-22-0 (3,4-dimethyl-phenyl)-[2-(6-trifluoromethyl-pyridin-3-yl)-ethyl]-amine 

Relevant academic research and scientific papers

COMPOUNDS USEFUL AS CSF1 MODULATORS

This invention relates to novel compounds and to pharmaceutical compositions comprising the novel compounds. More specifically, the invention relates to compounds useful as Colony Stimulating Factor 1 Receptor (cFMS) modulators (e.g. cFMS inhibitors). This invention also relates to processes for preparing the compounds, uses of the compounds in treatment and methods of treatment employing the compounds. Specifically, the invention relates to the use of the compounds for the treatment of cancer and autoimmune diseases.

HETEROAROMATIC MONOAMIDES AS OREXININ RECEPTOR ANTAGONISTS

The present invention is concerned with novel sulfonamides of formula wherein R1, R2, R3, R4, R5, Ar, Ar1, Ar2, n, o and p are as described in the description and claims. The compounds are orexin receptor antagonists that may be useful in the treatment of disorders, in which orexin pathways are involved.

4-(PYRIDIN-3-YL)-2-(PYRIDIN-2-YL)-1,2-DIHYDRO-3H-PYRAZOL-3-ONE DERIVATIVES AS SPECIFIC HIF-PROLYL-4-HYDROXYLASE INHIBITORS FOR TREATING CARDIOVASCULAR AND HAEMATOLOGICAL DISEASES

The object of the invention is to provide new compounds which can be used for the treatment of diseases, in particular cardiovascular and haematological diseases. The present invention describes compounds which act as specific HIF-prolyl-4-hydroxylase inhibitors and which, because of this specific in vivo action mechanism, induce HIF target genes, such as erythropoietin, and the thus produced biological processes, such as erythropoiesis, after parenteral or oral administration. The present invention relates to compounds having the general formula (I), in which A stands for CH or N, R1 stands for a substituent selected from the group formed by (C1-C6)-alkyl, trifluoromethyl, halogen, cyano, nitro, hydroxy, (C1-C6)-alkoxy, amino, (C1-C6)-alkoxycarbonyl, hydroxycarbonyl and C(=O)-NH-R4; R2 stands for a substituent selected from the group formed by halogen, cyano, nitro, (C1-C6)-alkyl, trifluoromethyl, hydroxy, (C1-C6)-alkoxy, trifluoromethoxy, amino, hydroxycarbonyl and C(=O)-NH-R8; m equals 0, 1 or 2; n equals 0, 1, 2 or 3, it being possible for these meanings to be the same or different when R1 or R2 occurs multiple times; and R3 stands for hydrogen, (C1-C6)-alkyl or (C3-C7)-cycloalkyl. The invention also relates to the salts, solvates, and salt solvates of these compounds.